ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Ritter Pharmaceuticals Inc

Ritter Pharmaceuticals Inc (RTTR)

0.448
0.00
(0.00%)
Al cierre: 04 Diciembre 3:00PM
0.448
0.00
( 0.00% )
Fuera de horario: -

Su centro para precios en tiempo real, ideas y debates en vivo

Estadísticas y detalles clave

Último Precio
0.448
Postura de Compra
0.4471
Postura de Venta
0.45
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.00 Rango de 52 semanas 0.00
Capitalización de Mercado [m]
Precio Anterior
0.448
Precio de Apertura
-
Hora
Última hora de negociación
-
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
-
Acciones en circulación
5,181,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-0.17
Beneficio por acción (BPA)
-2.59
turnover
-
Beneficio neto
-13.42M

Acerca de Ritter Pharmaceuticals Inc

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sede
Wilmington, Delaware, USA
Fundado
-

RTTR Últimas noticias

Ritter Pharmaceuticals, Inc. Announces Expected Closing of Merger Transaction with Qualigen, Inc.

LOS ANGELES, May 22, 2020 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals”, “Ritter” or the “Company”), today announced that its pending merger...

Ritter Pharmaceuticals, Inc. Announces Stockholder Approval of Proposals Required for Merger Transaction with Qualigen, Inc.

LOS ANGELES, May 19, 2020 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals”, “Ritter” or the “Company”), announced today that, based upon the final vote...

Ritter Pharmaceuticals, Inc. Announces Adjournment of its Special Meeting

LOS ANGELES, May 14, 2020 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter” or the “Company”), today announced that it has adjourned its special meeting of stockholders...

Ritter Pharmaceuticals Regains Compliance with Nasdaq’s Stockholders’ Equity Requirement for Continued Listing

LOS ANGELES, May 11, 2020 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), today announced that it has received written notice from...

Leading Independent Proxy Advisory Firms Recommend Ritter Pharmaceuticals Shareholders Vote in Favor of its Merger and Each o...

LOS ANGELES, May 06, 2020 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), today announced that Institutional Shareholder Services...

Ritter Pharmaceuticals Reports Financial Results for the First Quarter Ended March 31, 2020

LOS ANGELES, May 01, 2020 (GLOBE NEWSWIRE) -- Form S-4 Declared Effective by the SEC and Ritter/Qualigen Merger Voting is Underway Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter...

Ritter Pharmaceuticals, Inc. Urges Stockholders to Vote Now on Proposed Merger with Biotech Company, Qualigen Inc.

The merger CANNOT be consummated without the approval of EACH of the proposals being voted on at the Special Meeting, including approval of a reverse stock split. LOS ANGELES, April 28, 2020...

Ritter Pharmaceuticals, Inc. Announces Form S-4 Registration Statement Declared Effective by SEC

Special Meeting of Ritter Pharmaceuticals, Inc. Stockholders to Vote on Proposed Merger Scheduled for May 14, 2020 LOS ANGELES , April 16, 2020 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc...

Ritter Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2019

Definitive merger agreement with Qualigen, Inc. announced in January 2020 LOS ANGELES, March 31, 2020 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals”...

Ritter Pharmaceuticals, Inc. and Qualigen, Inc. Announce Merger Agreement

Transaction to Create a Nasdaq-listed Biotechnology Company Focused on Advancing Qualigen’s Cancer and Infectious Disease Therapeutic Development Programs LOS ANGELES, Jan. 21, 2020 (GLOBE...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
PRFXPainReform Ltd
US$ 4.01
(50.75%)
897.19k
PEVPhoenix Motor Inc
US$ 0.446
(20.28%)
6.12M
SBFMSunshine Biopharma Inc
US$ 3.40
(14.48%)
904.11k
VRNTVerint Systems Inc
US$ 29.30
(12.82%)
87.33k
CMCTCreative Media and Community Trust Corporation
US$ 0.31
(10.95%)
62.43k
BLUEbluebird bio Inc
US$ 0.5083
(-31.27%)
7.6M
BCAXBicara Therapeutics Inc
US$ 15.09
(-24.28%)
1.2k
UPXIUpexi Inc
US$ 4.07
(-18.76%)
85.55k
RENBRenovaro Inc
US$ 1.04
(-16.13%)
4.32k
HTOOFusion Fuel Green PLC
US$ 0.438
(-15.75%)
352.75k
BLUEbluebird bio Inc
US$ 0.5083
(-31.27%)
7.6M
PEVPhoenix Motor Inc
US$ 0.446
(20.28%)
6.12M
SMXSMX Security Matters Public Company
US$ 0.395
(3.57%)
3.76M
NVDANVIDIA Corporation
US$ 144.87
(-0.18%)
1.71M
JBLUJetBlue Airways Corporation
US$ 6.5506
(-0.07%)
1.44M

RTTR Discussion

Ver más
RickNagra RickNagra 4 años hace
Toast
👍️0
RickNagra RickNagra 4 años hace
Gonzo stock. See ya au revoir thanks for coming close the door on your way out good bye later alligator.
👍️0
Snug Harbour Snug Harbour 4 años hace
QLGN... Jackpot Baby... $5000 hit !!
👍️0
Termite7 Termite7 5 años hace
....and now it's GONE!!!
👍️0
Termite7 Termite7 5 años hace
Did this crappy thing go away...????



I suspected it was too good to be true!!!
👍️0
rawsteel rawsteel 5 años hace
Should not have to do anything from what I understand

.
They posted this in one of the news releases when they were soliciting votes.

"Ritter stockholders should also be aware that they will not be subject to a lock-up period following the merger".
👍️0
BigChris16 BigChris16 5 años hace
“Immediately following the closing, Ritter will be renamed “Qualigen Therapeutics, Inc.,” and is expected to trade on The Nasdaq Capital Market on a post-reverse stock split basis under the new ticker symbol “QLGN” beginning on Tuesday, May 26, 2020.”

Does that mean our shares just turn into QLGN? Or do we have to do something?
👍️0
maalapella maalapella 5 años hace
hold?
👍️0
rawsteel rawsteel 5 años hace
You're (everyone) welcome
👍️0
rawsteel rawsteel 5 años hace
They chose the lesser number of 25 for 1. I don't know about you but this merger and split may pan out to the good. May miss something good to get out.


Persons who hold Ritter common stock immediately prior to the reverse stock split and merger will be entitled to receive a distribution of nontransferable Ritter contingent value rights from the Company. The contingent value rights will provide their holders with potential cash payment rights in the event of certain monetizations (if any and if ever) within a certain time period of Ritter’s intellectual property related to modulation of the gut microbiome to treat gastrointestinal diseases.
👍️0
dillonview dillonview 5 años hace
We’ll take it. The wait was anxious. Thanks
👍️0
rawsteel rawsteel 5 años hace
Posted what John gave me in email. They were A day late.

Well a day later on the split and a few hours late on the news
👍️0
$Parabolic2030?$ $Parabolic2030?$ 5 años hace
Did you see the news ?
1 for 25

HE IS CORRECT.lol
👍️0
Golden Cross Golden Cross 5 años hace
RTTR Ritter Pharmaceuticals, Inc. Announces Expected Closing of Merger Transaction with Qualigen, Inc.
👍️0
dillonview dillonview 5 años hace
Your batting 0 on your inside info.
👍️0
rawsteel rawsteel 5 años hace
It's evident that with premarket trading they didn't split stock yesterday like was said would happen.??? They must have decided to wait. I was told news would be out this morning before market open. Let's see if that is true
👍️0
rawsteel rawsteel 5 años hace
There will be a release tomorrow prior to market open with details about the split.
👍️0
Tutu Tutu 5 años hace
Trash already in the 40's
👍️0
ClayTrader ClayTrader 5 años hace
* * $RTTR Video Chart 05-19-2020 * *

Link to Video - click here to watch the technical chart video

👍️0
rawsteel rawsteel 5 años hace
Based on the info I received: press release today of meeting results,which they did, after close Thursday stock would split which would mean it will start trading Friday under new ticker symbol QLGN. Just don't know the split number yet. They will probably do another press release Thursday after market close with that.
👍️0
BluSkies BluSkies 5 años hace
RTTR don’t have to do RS until NOV they can do it when ever they want?
👍️0
Denty Denty 5 años hace
Got 4000 shares .50 cents
👍️0
Denty Denty 5 años hace
Oh hell they back. This might go to .80 cents today
👍️0
rawsteel rawsteel 5 años hace
Yes. Mis-spoke, regained compliance
👍️0
Tutu Tutu 5 años hace
Exactly the stuff some people say
👍️0
aidytrader aidytrader 5 años hace
Rttr is already on the Nasdaq lol
👍️0
rawsteel rawsteel 5 años hace
Looks to be breaking down now for sure unless it can find support quick
👍️0
rawsteel rawsteel 5 años hace
RTTR on the way to the Nasdaq.

Pharmaceuticals (RTTR) said Tuesday its all-stock merger deal with Qualigen has received approval from Ritter stockholders and should be consummated in the next few days.
Under the agreement, pre-merger Ritter Pharmaceuticals stockholders will own approximately 7.5% of the post-merger combined company. On the other hand, the pre-merger Qualigen stockholders will own approximately 92.5% of the post-merger combined company on a fully-diluted basis.
Prior to closing, the company will change its name to Qualigen Therapeutics and continue trading on Nasdaq Capital Market under the symbol "QLGN."



Mergers and acquisitions (M&A) are forms of corporate restructuring that are becoming increasingly popular. The motive for wanting to merge with or acquire another company comes from management trying to achieve better synergy within the organization. This synergy is thought to increase the competitiveness and efficiency of the company. Mergers and acquisitions are also ways for a company to acquire capabilities it either cannot or does not want to develop internally, as well as to take over a company viewed as underperforming or undervalued and unlock value by changing operations or taking the company private.


Mergers usually occur on an all-stock basis. This means the shareholders of both merging companies are given the same value of shares in the new company that they owned in one of the old companies. Therefore, if a shareholder owned $10,000 worth of shares before the merger, he or she would own $10,000 in shares of the newly formed company after the merger. The number of shares owned would most likely change following the merger, but the value would remain the same.
👍️0
rawsteel rawsteel 5 años hace
Looks like it has found support and bounced off of the 200 sma for now
👍️0
rawsteel rawsteel 5 años hace
Guess we will know more Friday morning when it starts trading under the new ticker symbol. Hoping it's for the better
👍️0
$Parabolic2030?$ $Parabolic2030?$ 5 años hace
You’re right.. this is a positive ... cannot say that too often.

This will run once people realize it.
👍️0
Tutu Tutu 5 años hace
Selling off premarket
👍️0
rawsteel rawsteel 5 años hace
We haven't tanked yet. That's a POSITIVE

Ritter Pharmaceuticals, Qualigen All-Stock Merger Deal Gets Shareholder OK

08:37 AM EDT, 05/19/2020 (MT Newswires) -- Ritter Pharmaceuticals (RTTR) said Tuesday its all-stock merger deal with Qualigen has received approval from Ritter stockholders and should be consummated in the next few days.
Under the agreement, pre-merger Ritter Pharmaceuticals stockholders will own approximately 7.5% of the post-merger combined company. On the other hand, the pre-merger Qualigen stockholders will own approximately 92.5% of the post-merger combined company on a fully-diluted basis.
Prior to closing, the company will change its name to Qualigen Therapeutics and continue trading on Nasdaq Capital Market under the symbol "QLGN."

On a side note they did say before"Ritter stockholders should also be aware that they will not be subject to a lock-up period following the merger.”
👍️0
rawsteel rawsteel 5 años hace
Never have liked reverse splits but hopefully this one will be beneficial to the pps along with the merger. There may be others but only remember one that had reverse split and merger with name change that did extremely well afterwards. Maybe this will be another. GLTA
👍️0
BluSkies BluSkies 5 años hace
WOW NEWS ON BLOOMBERG!!

https://www.bloomberg.com/press-releases/2020-05-19/ritter-pharmaceuticals-inc-announces-stockholder-approval-of-proposals-required-for-merger-transaction-with-qualigen-inc
👍️0
rawsteel rawsteel 5 años hace
News out

LOS ANGELES , May 19, 2020 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals”, “Ritter” or the “Company”), announced today that, based upon the final vote count certified by the inspector of election for the special meeting of stockholders held on May 18, 2020 , its stockholders approved all of the Qualigen, Inc. merger-related proposals, including: (i) the issuance of Ritter common stock and convertible preferred stock pursuant to the Agreement and Plan of Merger, dated as of January 15, 2020 , as amended, by and among Ritter, RPG28 Merger Sub, Inc. , and Qualigen, Inc. (“Qualigen”) and the change of control of Ritter resulting from the merger, (ii) a reverse stock split of the outstanding shares of common stock of the Company, at a ratio within a range of 1-for-25 to 1-for-35, as determined by the board of directors of the Company, (iii) changing the name of Ritter from “Ritter Pharmaceuticals, Inc.” to “Qualigen Therapeutics, Inc.” and (iv) the adoption of Ritter’s 2020 Equity Incentive Plan.
“We’d like to recognize our shareholders for their strong participation and overwhelming support of this transaction with Qualigen,” said Andrew J. Ritter . “We look forward to completing the merger with Qualigen , a transaction which we believe will create continued value for our shareholders.”
As previously announced, the boards of directors of both Ritter and Qualigen unanimously approved the merger, which is expected to be consummated in the next few days. In connection with the closing of the transaction, the Company will change its name to “Qualigen Therapeutics, Inc.” and the Company’s shares are expected to continue trading on The Nasdaq Capital Market under the symbol “QLGN”.
👍️0
rawsteel rawsteel 5 años hace
Take it or leave it. You got what I was sent
👍️0
Tutu Tutu 5 años hace
I bet dumb ass keep your story's to your self
👍️0
rawsteel rawsteel 5 años hace
in my inbox
👍️0
Tutu Tutu 5 años hace
Where is the email
👍️0
rawsteel rawsteel 5 años hace
Email reply. Split after close Thursday
👍️0
BluSkies BluSkies 5 años hace
I hope so!! What makes you say that?
👍️0
rawsteel rawsteel 5 años hace
Hey Blu....Press release tomorrow. Hope it's GOOOOD
👍️0
BluSkies BluSkies 5 años hace
I didn’t recall they mentioned a date
👍️0
aidytrader aidytrader 5 años hace
Lololol SMH
👍️0
kingsransome kingsransome 5 años hace
they are delaying to dilute more shares for the r/s,,seen it many times,,crooks
👍️0
Tutu Tutu 5 años hace
Me as well
👍️0
Tutu Tutu 5 años hace
Crazy
👍️0
rawsteel rawsteel 5 años hace
Did u say everything was approved? and you were able to log in

When does split go into effect
👍️0
BluSkies BluSkies 5 años hace
Yes very thing was approved BS to delay meeting now news.
👍️0

Su Consulta Reciente

Delayed Upgrade Clock